Status:
UNKNOWN
Association of HMOs and Allergic Manifestations
Lead Sponsor:
Chulalongkorn University
Conditions:
Human Milk Oligosaccharides, Allergic Manifestation
Eligibility:
All Genders
Up to 2 years
Brief Summary
Compare the HMO composition in breast milk of infants with allergic manifestation (atopic dermatitis and food allergy) in the first 3 years of life, healthy infants with allergic mother and healthy in...
Detailed Description
* Parents of breast-fed infant from general pediatric clinic and allergy clinic of King Chulalongkorn Memorial Hospital were approached for informed about the research and ask to join this project * A...
Eligibility Criteria
Inclusion
- mothers with breast-fed infant with or without allergic manifestation
- Intend to participate for follow up and sign consent to participate in the study
Exclusion
- Mothers with any medical illness or high risk infant pregnant
- Infants with disease which affected allergic disease
- No inform consent
- Anything in the opinion of the investigator that would prevent children from completing the study
Key Trial Info
Start Date :
November 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 5 2019
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03256370
Start Date
November 1 2017
End Date
October 5 2019
Last Update
October 17 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chulalongkorn University
Pathum Wan, Bangkok, Thailand, 10330